Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

PURPOSE: To evaluate the tolerability of escalating doses of stereotactic body radiation therapy in the treatment of localized prostate cancer. PATIENTS AND METHODS: Eligible patients included those with Gleason score 2 to 6 with prostate-specific antigen (PSA) ≤ 20, Gleason score 7 with PSA ≤ 15, ≤...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boike, Thomas P., Lotan, Yair, Cho, L. Chinsoo, Brindle, Jeffrey, DeRose, Paul, Xie, Xian-Jin, Yan, Jingsheng, Foster, Ryan, Pistenmaa, David, Perkins, Alida, Cooley, Susan, Timmerman, Robert
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2011
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138546/
https://ncbi.nlm.nih.gov/pubmed/21464418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.4377
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars